Adimmune Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 1,087.29 million compared to TWD 753.34 million a year ago. Net income was TWD 419.52 million compared to TWD 160.98 million a year ago. Basic earnings per share from continuing operations was TWD 0.98 compared to TWD 0.37 a year ago. Diluted earnings per share from continuing operations was TWD 0.98 compared to TWD 0.37 a year ago. Basic earnings per share was TWD 0.98 compared to TWD 0.37 a year ago. Diluted earnings per share was TWD 0.98 compared to TWD 0.37 a year ago.
For the nine months, sales was TWD 1,667.02 million compared to TWD 848.28 million a year ago. Net income was TWD 230.21 million compared to net loss of TWD 251.8 million a year ago. Basic earnings per share from continuing operations was TWD 0.54 compared to basic loss per share from continuing operations of TWD 0.59 a year ago. Diluted earnings per share from continuing operations was TWD 0.54 compared to diluted loss per share from continuing operations of TWD 0.59 a year ago. Basic earnings per share was TWD 0.54 compared to basic loss per share of TWD 0.59 a year ago. Diluted earnings per share was TWD 0.54 compared to diluted loss per share of TWD 0.59 a year ago.